Similar articles

• Oestrogen content of oral contraceptives and thromboembolism.

  McQueen EG. McQueen EG. N Z Med J. 1970 May;71(456):317. N Z Med J. 1970. PMID: 5270982 No abstract available.
• Estrogens and thromboembolic diseases. Present conception of a controversial issue.

  Zador G. Zador G. Acta Obstet Gynecol Scand Suppl. 1976;54:13-28. Acta Obstet Gynecol Scand Suppl. 1976. PMID: 788441 Review. No abstract available.
• Combined oral contraceptives. A statement by the committee on safety of drugs.

  [No authors listed] [No authors listed] Br Med J. 1970 Apr 25;2(5703):231-2. doi: 10.1136/bmj.2.5703.231. Br Med J. 1970. PMID: 5443411 Free PMC article. No abstract available.
• [Vascular pathology secondary to administration of estroprogestogens].

  Serban MD. Serban MD. Stud Cercet Endocrinol. 1971;22(2):99-112. Stud Cercet Endocrinol. 1971. PMID: 4105297 Romanian. No abstract available.
• Monitoring side effects of contraceptives.

  Hill AB. Hill AB. Acta Endocrinol Suppl (Copenh). 1974;185:279-95. doi: 10.1530/acta.0.075s279. Acta Endocrinol Suppl (Copenh). 1974. PMID: 4593796 Review. No abstract available.